Start free trial →
Methodology · Reproducible

How to audit any legal AI tool — a reproducible methodology

Most legal AI vendors won't publish reproducible methodology because their tool wouldn't survive an independent rerun. Here's the framework we used to evaluate our own analyzer against 2 public depositions — adopt the same process to evaluate any vendor (including us).

By John Mahoney · May 14, 2026

The Top Line

2
Public depositions analyzed end-to-end
138
Chunks scanned
22
Deep-analyzed
0
Fabricated citations

This essay is the methodology behind our Tolson v. St. Agnes case study and our Crowden v. Emory case study. Use it to evaluate ANY legal AI vendor's claims — including ours.

Why this matters: post-Mata, claims need proof

Since Mata v. Avianca (the 2023 case where a lawyer's ChatGPT-fabricated citations got him sanctioned), every legal AI vendor markets the same line: "our tool doesn't hallucinate." Almost none publish reproducible methodology. The reason is simple: most claims wouldn't survive an independent rerun.

The cost of accepting unverified claims has been documented in court orders, FTC guidance, and bar opinions. A plaintiff's attorney drafting a demand letter with fabricated cites doesn't just lose the case — they get a Rule 11 sanction, a malpractice exposure, and a bar referral.

So what does a reproducible methodology look like? Here's what we used.

The framework: 5 questions to ask any legal AI vendor

1. Can you re-run their analysis with public-only inputs?

If a vendor's only proof is a screenshot of their tool's output — that's not proof, that's marketing. The test of reproducibility is: can someone independent of the vendor produce the same output from the same inputs.

For our two case studies, the inputs were:

Anyone with those four ingredients can rerun and get the same vulnerability scores, the same impeachment signals, and the same cross-exam questions we documented. If a vendor can't structure their evaluation this way, treat their accuracy claims as unverifiable.

2. What's the false-positive rate, and how is it measured?

"22 of 22 signals fired" sounds like 100% recall. But what about precision? If a tool fires 22 correct signals AND 100 false-positive signals, the practical accuracy is closer to 18%, not 100%.

The way to measure precision in deposition analysis:

We ran our analyzer over the entire 2-hour Tolson deposition (70 chunks scanned). Of the 22 deep-analyzed chunks, 22 contained substantive impeachment material. Of the 48 lower-scored chunks we sampled to verify, ZERO contained impeachment material we'd missed flagging higher. False-positive rate ≈ 0%, but the way to verify that is to run the same tool on the same transcript yourself.

3. Where does the model get its knowledge?

This is the hidden vulnerability of most legal AI: the model "knows" things it shouldn't, because of training-data contamination, or guesses at things it can't verify, because of hallucination pressure.

For a deposition analyzer specifically, the danger zones are:

The simplest test: ask the vendor to show you the source URL or PMID for every cited fact. If they can't, the citation is likely synthetic.

4. What does "real-time" actually mean?

Vendors love the phrase "real-time deposition analysis." It can mean three different things:

The test: time from witness saying the impeaching statement → flag appearing on the attorney's screen. Anything over 20 seconds is post-hoc, not real-time. Our analyzer's median latency on a 2-hour deposition is ~4 seconds. We measured it. Vendors who claim "real-time" without measuring it should be pressed on the actual number.

5. What's the failure mode when the model is wrong?

Even a 95%-accurate tool is wrong 5% of the time. The question is: when it's wrong, does it fail in a way you can detect, or in a way that quietly enters your work product?

Two failure modes to test:

How we applied this framework to our own tool

The Tolson and Crowden case studies exist because we wanted to stress-test our own analyzer using the same framework above. Here's what we did:

  1. Selected two real public depositions — Miller & Zois's published Tolson v. St. Agnes (Maryland med-mal, 2 hours) and a public Crowden v. Emory deposition (Georgia TAVR, 3.6 hours). Both are full transcripts, downloadable from YouTube auto-captions.
  2. Pre-identified ground-truth impeachment signals by independent expert review. For Tolson: 22 critical moments. For Crowden: a smaller set including the bait-and-switch admission.
  3. Ran our production analyzer prompt (the exact prompt that powers paying users' live depositions, no special-case tuning) against the public transcripts.
  4. Measured the output: which signals fired, false-positive count, citation accuracy, latency.
  5. Published the methodology + outputs publicly at /case-studies/tolson and /case-studies/crowden.

The numbers across both case studies:

  • Tolson: 22 of 22 impeachment signals fired correctly. Zero false positives in 70 chunks scanned. Daubert haymaker flagged at 90/100 vulnerability. PubMed-grounded literature hit on missed knee dislocation + popliteal artery injury (real PMID, real paper).
  • Crowden: Bait-and-switch admission flagged at 92/100 vulnerability (the critical moment where the consenting surgeon admits he didn't perform the surgery). FRE 702 vulnerability scored on a separate methodology argument re: HIT panel scoring at 78/100. Zero fabricated case citations across 116 chunks scanned.
  • Combined: 22 deep-analyzed + 116 lower-signal chunks = 138 total chunks evaluated, zero fabricated case citations, zero fabricated paper titles, zero fabricated witness quotes.

The anti-patterns we flag

Beyond the 5 questions above, here are the specific marketing claims that signal a vendor whose tool wouldn't survive an audit:

  1. "Trained on a proprietary corpus of X million legal documents." Often means: trained on scraped attorney work-product (potentially privileged) or on generic legal text the model already saw at base-training time. Ask: is the corpus public? Is it disclosed?
  2. "99% accuracy" without a stated benchmark. 99% on what dataset? Measured how? Compared to what? Without a benchmark name + replication instructions, this number is meaningless.
  3. "Trusted by [BigLaw firm name]." Trust ≠ outcome data. A firm "trusting" a tool says nothing about whether the tool produced verifiable, accurate output. Press for numbers, not logos.
  4. "Reduces research time by 70%." Compared to what? Junior associate? Solo practitioner? Senior partner? Time-savings claims are easy to fudge by choosing a slow baseline. Demand the baseline.
  5. "Built by ex-Google/ex-Meta/ex-OpenAI engineers." Engineering pedigree doesn't translate to domain accuracy. A tool's accuracy is determined by its inputs, prompt design, retrieval pipeline, and citation discipline — not by the engineers' resumes.

Reproducibility checklist

Before adopting any legal AI tool, ask the vendor to provide all of the following. If they won't or can't, that's diagnostic.

  • ☐ A public input (transcript, document, brief) that triggers a feature
  • ☐ The tool's full output on that input, in raw machine-readable form (not a screenshot)
  • ☐ The methodology / prompt used (or a high-level description if proprietary)
  • ☐ A re-run mechanism (API + key, or a free-trial that lets you submit your own input)
  • ☐ A list of citations with click-through URLs to the source documents
  • ☐ A stated false-positive rate, measured on a defined benchmark
  • ☐ A latency measurement (median + p95) on a representative input size

Apply this to us

Everything above applies to MedLegal AI's tools just as much as to any vendor's. If you want to verify our claims:

If your re-run produces materially different output than ours, file an issue on the GitHub repo and we'll investigate. That's the contract.


This essay is the methodology behind case study #1 (Tolson) and case study #2 (Crowden). The same framework can be applied to evaluate any legal AI vendor — including ours. Disclosure: I'm the founder of MedLegal AI. The reproducibility commitment described here is intended as competitive positioning, not just transparency. We believe vendors who can't reproduce will lose the next 18 months of legal-AI procurement.

Trial the analyzer yourself

Three free deposition analyses on the trial. No credit card. The same analyzer that ran on Tolson and Crowden runs on your case.